We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

39 hedge funds and large institutions have $5.45M invested in Statera Biopharma, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

448% more call options, than puts

Call options by funds: $137K | Put options by funds: $25K

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

5% less funds holding

Funds holding: 41 → 39 (-2)

26% less capital invested

Capital invested by funds: $7.34M → $5.45M (-$1.89M)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
8
Closed
6
Calls
$137K
Puts
$25K
Net Calls
+$112K
Net Calls Change
-$355K

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$130K
2
Renaissance Technologies
Renaissance Technologies
New York
+$120K
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$62.7K
4
VKH
Virtu KCG Holdings
New York
+$58.9K
5
AW
ACG Wealth
Georgia
+$43K

Top Sellers

Rank Fund Capital Flow
1
BC
BHR Capital
New York
-$468K
2
GIG
Goodnow Investment Group
Connecticut
-$51.7K
3
WF
WealthTrust Fairport
Ohio
-$31K
4
Wells Fargo
Wells Fargo
California
-$17.5K
5
Morgan Stanley
Morgan Stanley
New York
-$11K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.57M – – –
LTFS
2
Ladenburg Thalmann Financial Services
Florida
$999K – – –
PGCM
3
Prescott Group Capital Management
Oklahoma
$750K – – –
GIG
4
Goodnow Investment Group
Connecticut
$656K -$51.7K -1,900 -6%
RHJA
5
Rice Hall James & Associates
California
$184K +$130K +4,785 +156%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$155K -$952 -35 -0.5%
Jacobs Levy Equity Management
7
Jacobs Levy Equity Management
New Jersey
$135K +$62.7K +2,305 +67%
BFA
8
BlackRock Fund Advisors
California
$134K +$6.5K +239 +4%
California Public Employees Retirement System
9
California Public Employees Retirement System
California
$129K – – –
Renaissance Technologies
10
Renaissance Technologies
New York
$103K +$120K +4,415 New
Northern Trust
11
Northern Trust
Illinois
$85K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$83K – – –
VKH
13
Virtu KCG Holdings
New York
$68K +$58.9K +2,167 +288%
OC
14
Oppenheimer & Co
New York
$46K -$10.4K -382 -16%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$41K – – –
AW
16
ACG Wealth
Georgia
$37K +$43K +1,580 New
BA
17
BlackRock Advisors
Delaware
$24K +$13K +479 +85%
Neuberger Berman Group
18
Neuberger Berman Group
New York
$23K – – –
State Street
19
State Street
Massachusetts
$23K – – –
VCAM
20
Van Cleef Asset Management
Ohio
$23K – – –
GC
21
Guggenheim Capital
Illinois
$23K +$1.6K +59 +6%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$22K – – –
Morgan Stanley
23
Morgan Stanley
New York
$18K -$11K -406 -34%
Cambridge Investment Research Advisors
24
Cambridge Investment Research Advisors
Iowa
$18K -$136 -5 -0.7%
TAM
25
Taurus Asset Management
New York
$18K – – –
1
2

STAB Hedge Fund Activity: Q4 2013 in Review

39 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q4 2013, worth a combined $5.45M — down 26% from $7.34M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of STAB and 4 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $130K. The largest seller was BHR Capital, exiting entirely with an estimated $468K sold.

  • 39 institutional investors held Statera Biopharma, Inc. Common Stock (STAB) as of Q4 2013, down from 41 in Q3 2013.
  • Funds reported $5.45M of Statera Biopharma, Inc. Common Stock stock for Q4 2013, down 26% quarter-over-quarter.
  • 4 funds opened new Statera Biopharma, Inc. Common Stock positions in Q4 2013 and 6 closed out, a net change of -2 holders.
  • The largest Statera Biopharma, Inc. Common Stock buyer in Q4 2013 was Rice Hall James & Associates, an estimated $130K added.
  • The largest Statera Biopharma, Inc. Common Stock seller in Q4 2013 was BHR Capital, an estimated $468K sold.

Based on aggregated 13F filings for Q4 2013.